HIV Infections: all 4,342 studies
Page 31 of 44. Open to participants first (242), then studies with results posted, then the rest; newest registration first within each.
- The Pharmacokinetics of Double Boosted Protease Inhibitors in Antiretroviral-naive HIV-1 Infected PatientsCompletedNCT00400738Phase 2
- Drug Interaction - Oral ContraceptiveCompletedNCT00399685Phase 1
- Nevirapine Plus Zidovudine to Prevent Perinatal HIV in ThailandCompletedNCT00398684Phase 3
- Monotherapy Versus Placebo Over 10 Days in Integrase Naive HIV-1 Infected AdultsCompletedNCT00398125Phase 2
- A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected SubjectsWithdrawnNCT00397566Phase 2
- Decision-Making of Hispanics and African-Americans With HIV/AIDS Participating in Clinical TrialsCompletedNCT00394004
- C2P Mobilization Intervention (Pilot)CompletedNCT00393575Not applicable
- Bioequivalence Study of Atazanavir 300 mg CapsuleCompletedNCT00393328Phase 1
- HIV Testing in Pregnant Women: Evaluating an Opt-Out Testing StrategyCompletedNCT00393302
- Safety/Effectiveness of Oral Chemokine Coreceptor 5 (CCR5) Antagonist INCB009471 in R5-tropic HIV Infected PatientsCompletedNCT00393120Phase 2
- Single-Blind, Controlled Safety and Immunogenicity Study of Recombinant MVA Virus to Treat HIV InfectionCompletedNCT00390078Phase 1/2
- BASIC: Boosted Atazanavir or Saquinavir Induced Lipid ChangesCompletedNCT00389402Phase 4
- A Pilot Study for Toxicity Evaluation of HIV Rectal MicrobicidesCompletedNCT00389311Early Phase 1
- PREventing Progression of Adipose Tissue RedistributionCompletedNCT00389194Phase 4
- BLADE: Comparison of Once Daily Lopinavir/Ritonavir to Lopinavir/Ritonavir BID Dosing in HIV-Infected SubjectsStatus unknownNCT00388492
- Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated With Lopinavir or Efavirenz.TerminatedNCT00386659Phase 4
- Safety and Immunogenicity Study of Recombinant Modified Vaccinia Virus Ankara (MVA) Virus to Treat HIV InfectionCompletedNCT00386633Phase 1
- A Study To Evaluate Formulations And Food Effect On GSK364735 In Healthy Subjects.CompletedNCT00386347Phase 1
- Shortened Zidovudine Regimens to Prevent Mother-to-Child Transmission of HIV Type 1CompletedNCT00386230Phase 3
- Effects of Two Anti-HIV Drug Regimens on HIV Transmission Risk Behavior Among SMART Study ParticipantsCompletedNCT00386035
- Immunological and Viral Response to Antiretrovirals in HIV Patients With CD4 Cell Count Below 100CompletedNCT00385957Phase 4
- Atazanavir or Lopinavir in HIV Post-exposure ProphylaxisCompletedNCT00385645Phase 4
- Effects of Two Anti-HIV Drug Regimens on Quality of Life and Health Care Use Among SMART Study ParticipantsCompletedNCT00385632
- A Trial of PEHRG214 in HIV-Infected PatientsTerminatedNCT00385567Phase 2
- Botswana Study of UC-781 Vaginal MicrobicideWithdrawnNCT00385554Phase 1
- Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected PatientsCompletedNCT00384904Phase 4
- Safety of and Immune Response to a DNA HIV Vaccine Followed by an Adenoviral Vaccine Boost Given Three Different Ways to HIV Uninfected AdultsCompletedNCT00384787Phase 1
- C2P - Phase III: MPowerment and Community PromiseCompletedNCT00381784Not applicable
- HIV Prevention in the Primary Care SettingCompletedNCT00381524Not applicable
- A Pilot Study to Investigate the Safety and Immunologic Activity AGS-004 an Autologous HIV Immunotherapeutic Agent.CompletedNCT00381212Phase 1/2
- Open-Label, 48-Week Extension Study of Elvucitabine in Combination With Background Antiretroviral Therapy (ART) for Participants Who Have Completed Study ACH443-014ACompletedNCT00380159Phase 2
- Saquinavir/Ritonavir in Single Therapy as Maintenance TreatmentCompletedNCT00379405Phase 4
- HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men.CompletedNCT00378976Phase 3
- Effect Study of a Theory-Based Internet Intervention on Safe-Sex PracticesTerminatedNCT00378885Not applicable
- Collection of Blood Samples From SMART Study Participants for Future Genetic StudiesCompletedNCT00377169
- Early Access of MK0518 in Combination With an Optimized Background Antiretroviral Therapy (0518-023)Approved for marketingNCT00377065
- Safety of and Immune Response to a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected AdultsCompletedNCT00376090Phase 1
- Short Course Intermittent Regimens for the Treatment of HIV-Associated TuberculosisStatus unknownNCT00376012Phase 3
- Mefloquine Prophylaxis in HIV-1 Individuals: a Randomized Placebo-controlled TrialCompletedNCT00373048Not applicable
- SPL7013 Gel - Male Tolerance StudyCompletedNCT00370357Phase 1
- Safety Study Of Nasal HIV Vaccine Adjuvanted With LTK63TerminatedNCT00369031Phase 1
- A Long Term, Safety Study of Apricitabine in HIV-infected SubjectsCompletedNCT00367952Phase 2
- Viral Load Determination and Biomarkers of High Risk Human Papillomavirus (HPV) - Types in HIV-positive MenStatus unknownNCT00365729
- Effectiveness of a Telephone-Delivered Behavioral Treatment to Improve the Quality of Life of Older Adults With HIVCompletedNCT00365690Phase 2/3
- Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected PatientsCompletedNCT00365612Phase 4
- Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/TenofovirCompletedNCT00365339Phase 1
- Drug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate RosiglitazoneCompletedNCT00362726Phase 1
- GMB: Study of Truvada (TDF+FTC) or Emtricitabine (FTC) Alone Versus HAART Interruption in HIV-Infected Patients With ResistanceCompletedNCT00362687Phase 4
- A Study of AMD11070 in HIV-infected Patients Carrying X4-tropic VirusCompletedNCT00361101Phase 1
- Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV Co-infected PatientsCompletedNCT00358696Phase 4
- Atazanavir Twice DailyCompletedNCT00357721Phase 1
- Atazanavir and Ritonavir (ATV/RTV) and an Oral Contraceptive in Healthy FemalesCompletedNCT00357604Phase 1
- Drug Interaction Study With Proton Pump InhibitorCompletedNCT00357240Phase 1
- Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy SubjectsCompletedNCT00357188Phase 1
- Immuno-Virological Efficacy of Combination With Trizivir +Tenofovir in Multiresistant HIV PatientsTerminatedNCT00356616Phase 4
- Viral Kinetics of Treatment With Peginterferon Alpha-2a, Ribavirin and Epoetin β in Patients Coinfected HCV/HIVCompletedNCT00356486Phase 4
- Improving HIV Prevention Skills in People With Serious Mental IllnessesCompletedNCT00356291Phase 2
- Study to Evaluate the Influence of Nevirapine to Atazanavir in Steady State Equilibrium in HIV PatientsCompletedNCT00355719Phase 4
- A Phase 2 Study to Evaluate Pharmacokinetics, Safety and Efficacy of TMC114/Ritonavir (Rtv) in Human Immunodeficiency Virus (HIV)-1 Infected Children and AdolescentsCompletedNCT00355524Phase 2
- Study of the Effectiveness of Passive Immunotherapy in HIV-Infected Patients Who Are in Virologic FailureSuspendedNCT00353327Phase 2/3
- Pharmacokinetics of Apricitabine and Tipranavir When Dosed Alone or TogetherCompletedNCT00352066Phase 1
- Preventive Therapy for Tuberculosis in HIV Infected PersonsCompletedNCT00351702Phase 3
- Buprenorphine HIV Care Integration ProjectCompletedNCT00348868Not applicable
- Pharmacokinetics and Pharmacodynamics of an Anti-HIV Drug in Israeli Ethiopian and Non-Ethiopian PopulationsWithdrawnNCT00347750
- Evaluating Host and Viral Factors Among HIV Infected Former Commercial Blood Donors in Fuyang, Anhui Province, ChinaCompletedNCT00346762
- Backup With Combivir or Single Dose (SD) Truvada in Order to Avoid Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) Resistance After SD Nevirapine for the Prevention of Mother-to-child Transmission (PMTCT)CompletedNCT00346567Not applicable
- Safety and Durability ofTenofovir and a Cell Cycle Agent for Viral SuppressionCompletedNCT00344981Not applicable
- A Study to Evaluate of the Efficacy of Enfuvirtide During the Induction Phase of TherapyCompletedNCT00344760Phase 4
- Effectiveness of Structured Ecosystems Therapy for Reducing HIV Risk Behaviors and Improving Treatment Adherence in HIV Infected Men Released From PrisonCompletedNCT00344591Phase 2
- Pharmacokinetic (PK) Study of Single-dose Rosuvastatin and Tipranavir/Ritonavir in Healthy SubjectsCompletedNCT00344123Phase 1
- Tucaresol As Add-On To HAART (Highly Active Antiretroviral Therapy) In Chronic HIV-1 Infected AdultsCompletedNCT00343941Phase 2
- Modified Directly Observed Therapy for Improving Antiretroviral Therapy Adherence in People With HIVCompletedNCT00339092Not applicable
- Study to Evaluate Changes in CD4 on Replacing TDF With ABC or DDI+TDF With ABC+3TCCompletedNCT00338390Phase 3
- Pharmacokinetic Study Of EPZICOM TabletCompletedNCT00337922Phase 4
- Phase 1 Pilot Study of an ART Bridging Regimen in Highly Experienced Patients Unable to Achieve Viral SuppressionCompletedNCT00336778Phase 1
- A Randomized Trial of IUD Versus Hormonal Contraception in HIV-infected Women in ZambiaCompletedNCT00336245Phase 3
- Study on the Effect of Kaletra + Nevirapine as Maintenance Bitherapy Compared to a Triple Therapy Including Kaletra + Analogues in HIV PatientsCompletedNCT00335686Phase 4
- A Study to Investigate the Cardiovascular Safety of Apricitabine in Healthy SubjectsCompletedNCT00334659Phase 1
- Tenofovir/Emtricitabine for PMTCT in Africa and Asia (ANRS 12109 TEmAA)CompletedNCT00334256Phase 2
- Leukapheresis to Obtain Lymphocytes for Studies on Antiretroviral Naive HIV-infected PatientsCompletedNCT00333892
- Study to Assess Safety and Quality of Life of Patients Using Biojector Versus Needles for Fuzeon AdministrationCompletedNCT00333736Phase 2
- Safety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-AlcamidCompletedNCT00333684Phase 2
- Safety and Feasibility Study of Dapivirine (TMC120) Vaginal Ring in BelgiumCompletedNCT00332995Phase 1
- Stepping Stones Program for Preventing HIV Infection in Residents of Rural South African CommunitiesCompletedNCT00332878Phase 3
- Safety and Efficacy of Two Once Daily Anti Retroviral Treatment Regimens Along With Anti-tuberculosis TreatmentStatus unknownNCT00332306Phase 3
- The Effect of Bacille Calmette Guerin (BCG) Vaccination on Immune Responses in HIV-Exposed and Unexposed InfantsStatus unknownNCT00331474Phase 1/2
- Observational Study of Changes in Fat Distribution and Blood Metabolites in HIV Infected AdultsStatus unknownNCT00331448
- Multidisciplinary Inpatient Palliative Care InterventionCompletedNCT00325611Not applicable
- HIV Prevention Intervention for CouplesCompletedNCT00325585Phase 2
- Safety Study of Once a Day ART and Opiate Substitute.CompletedNCT00324688Phase 4
- Structured Treatment Interruptions in Chronic HIV InfectionCompletedNCT00324103Phase 3
- SWEET: Once Daily Truvada Versus Twice Daily Combivir for the Treatment of HIV InfectionCompletedNCT00323544Phase 3
- Observational Study of HIV-Infected Subjects With X4-Tropic or Non-Phenotypeable VirusTerminatedNCT00321438
- Phase I Study of Vaccination Schedule of Experimental HIV VaccinesCompletedNCT00321061Phase 1
- Comparison of Abacavir Following Once-Daily And Twice-Daily Administration In HIV Infected SubjectsCompletedNCT00320307Phase 1
- Study to Evaluate the Effectiveness of ABC+3TC +EFV in Once-Daily Regimens Versus KLT in Twice-Daily Regimens in Naive HIV PatientsCompletedNCT00318123Phase 3
- An Open-Label Study to Evaluate the Effect of Every Other Week PROCRIT� (Epoetin Alfa) Dosing (40,000-60,000 Units) On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients (CHAMPS II)CompletedNCT00317902Phase 4
- Buprenorphine and Integrated HIV CareCompletedNCT00317460Phase 4
- Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once DailyCompletedNCT00314626Phase 3
- A Mindfulness Based Approach to HIV Treatment Side EffectsCompletedNCT00312936Phase 1/2